Prevalence and antibiotic resistance of Mycoplasma hominis and Ureaplasma urealyticum in Chongming District, Shanghai, China from 2020 to 2023
Abstract
Ureaplasma urealyticum (UU) and Mycoplasma hominis (MH) can lead to various genital and extragenital infections, with antibiotic resistance growing and varying wordwide. This study aims to investigate the prevalence and antibiotic resistance profiles of MH and UU in outpatients in Shanghai, China, from 2020 to 2023. A facility-based cross-sectional study was conducted from January 1, 2020 to December 31, 2023. Trends of MH, UU and coinfection (MH and UU coinfection), rate of antibiotic resistance during 2020 and 2023 were analyzed based on Cochran-Armitage trend test. We analyzed the prevalence and antibiotics resistance rate base on chi-square test or a single sample t-test. Our study indicated that the overall positive rate of MH, UU and coinfection were 13.47%, 32.13%, and 11.21%, respectively. For age, the trend of positive rate of UU decreased significantly (Z = -3.62, P < .001). Furthermore, the positive rate of UU increased from 31.82% in 2020 to 47.92% in 2023 (Z = 1.98, P < .05). During 2020 and 2023, Methomycin and strong bacteriocins maintained high activity against both MH and UU, with resistance rates <5%. But roxithromycin (85.48%), azithromycin (75.81%), and levofloxacin (70.97%) showed limit activity for MH, and levofloxacin (44.78%), sparfloxacin (37.36%), and azithromycin (29.40%) showed limit activity for UU. Between 2020 and 2023, the rate of antibiotic resistance to azithromycin, clarithromycin, roxithromycin, methomycin, strong bacteriocins,…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.